How to remain a top CDMO in ADC-led oncology
CDMOs in therapeutics worldwide are facing multiple challenges, including new regulations, changes in tariffs, supply chain disruptions, and the need to do more with less. We look at ways for CDMOs to remain at the forefront of ADC-led oncology.
